Sapitinib difumurate is a salt form of an active pharmaceutical ingredient. It is a quinazoline-based compound that contains a piperidine ring and functional groups including amide, ether, and halogen, and is supplied as a research-grade chemical.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1196531-39-1
Cis-tranexamic acid
pharmaceutical raw material
Tranexamic acid
pharmaceutical raw material
Phentermine hydrochloride
pharmaceutical raw material
Levomedetomidine
pharmaceutical raw material
Poziotinib
pharmaceutical raw material
bis((E)-but-2-enedioic acid);2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide
LSXKPHWAKWZIKV-LVEZLNDCSA-N
CNC(=O)CN1CCC(CC1)OC2=C(C=C3N=CN=C(C3=C2)NC4=C(C(=CC=C4)Cl)F)OC.C(=C/C(=O)O)\C(=O)O.C(=C/C(=O)O)\C(=O)O